syndrome	score	normalized_score
#610198 3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5;;CARDIOMYOPATHY, DILATED, WITH ATAXIA; DCMA;;MGA, TYPE V; MGA5	0.14285699999999998	100.0
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.14285699999999998	100.0
#231690 GLUTARIC ACIDURIA III;;GA III;;GLUTARYL-CoA OXIDASE DEFICIENCY	0.14285699999999998	100.0
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.14285699999999998	100.0
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.14285699999999998	100.0
GLUTARIC ACIDEMIA I; GA1	0.14285699999999998	100.0
MCLEOD SYNDROME; MCLDS	0.10480316000000002	73.36228536228539
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.1	70.00007000007001
PITUITARY ADENOMA 2, GROWTH HORMONE-SECRETING; PITA2	0.1	70.00007000007001
PITUITARY ADENOMA 5, MULTIPLE TYPES; PITA5	0.1	70.00007000007001
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.1	70.00007000007001
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.1	70.00007000007001
CARNEY COMPLEX, TYPE 1; CNC1	0.1	70.00007000007001
104600 AMENORRHEA-GALACTORRHEA SYNDROME	0.1	70.00007000007001
#174800 MCCUNE-ALBRIGHT SYNDROME; MAS;;ALBRIGHT SYNDROMEPOLYOSTOTIC FIBROUS DYSPLASIA, INCLUDED; PFD, INCLUDED; POFD, INCLUDED	0.1	70.00007000007001
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.1	70.00007000007001
CHROMOSOME Xq26.3 DUPLICATION SYNDROME	0.1	70.00007000007001
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.0953653	66.75577675577676
COWDEN SYNDROME 5; CWS5	0.0909091	63.63643363643365
BASAL CELL NEVUS SYNDROME	0.0909091	63.63643363643365
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.0909091	63.63643363643365
AICARDI SYNDROME; AIC	0.0909091	63.63643363643365
SECKEL SYNDROME 10; SCKL10	0.0909091	63.63643363643365
#610706 DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA;;DEAFNESS, CONGENITAL, WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA;;DEAFNESS WITH LAMM	0.0909091	63.63643363643365
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.0909091	63.63643363643365
BARTSOCAS-PAPAS SYNDROME; BPS	0.0909091	63.63643363643365
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.0909091	63.63643363643365
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.0909091	63.63643363643365
COWDEN SYNDROME 6; CWS6	0.0909091	63.63643363643365
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.0766902	53.683193683193686
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0766902	53.683193683193686
GITELMAN SYNDROME	0.0757575	53.03030303030304
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.07432156000000001	52.02514402514403
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.07432156000000001	52.02514402514403
PHOSPHOGLYCERATE MUTASE, MUSCLE, DEFICIENCY OF	0.07432156000000001	52.02514402514403
#615156 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL DOMINANT, 6; PEOA6;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT, 6	0.07223940000000001	50.56763056763059
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.0650623	45.543655543655554
GLYCOGEN STORAGE DISEASE XI; GSD11	0.0650623	45.543655543655554
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.0615387	43.077133077133084
SENGERS SYNDROME	0.05917006	41.41908341908342
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.05917006	41.41908341908342
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.05471376	38.299670299670304
MUCOPOLYSACCHARIDOSIS, TYPE II	0.0526316	36.84215684215685
XIA-GIBBS SYNDROME	0.0526316	36.84215684215685
SCHEIE SYNDROME	0.0526316	36.84215684215685
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0526316	36.84215684215685
TURNPENNY-FRY SYNDROME; TPFS	0.0526316	36.84215684215685
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.0526316	36.84215684215685
COSTELLO SYNDROME; CSTLO	0.0526316	36.84215684215685
APNEA, OBSTRUCTIVE SLEEP	0.0526316	36.84215684215685
MARSHALL-SMITH SYNDROME; MRSHSS	0.0526316	36.84215684215685
MARFANOID HABITUS WITH SITUS INVERSUS	0.0526316	36.84215684215685
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.0526316	36.84215684215685
DYSOSTEOSCLEROSIS	0.0526316	36.84215684215685
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.0526316	36.84215684215685
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.0526316	36.84215684215685
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0526316	36.84215684215685
HURLER-SCHEIE SYNDROME	0.0526316	36.84215684215685
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.0526316	36.84215684215685
HALLERMANN-STREIFF SYNDROME; HSS	0.0526316	36.84215684215685
OBSESSIVE-COMPULSIVE DISORDER 1	0.050089400000000006	35.06261506261507
RAYNAUD-CLAES SYNDROME; MRXSRC	0.050089400000000006	35.06261506261507
DYSTONIA 11, MYOCLONIC	0.050089400000000006	35.06261506261507
PHENYLKETONURIA	0.050089400000000006	35.06261506261507
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.050089400000000006	35.06261506261507
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.050089400000000006	35.06261506261507
BARTH SYNDROME; BTHS	0.0499108	34.93759493759494
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0499108	34.93759493759494
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.0454545	31.818181818181824
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.0454545	31.818181818181824
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	0.0454545	31.818181818181824
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.0454545	31.818181818181824
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0454545	31.818181818181824
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0454545	31.818181818181824
#145600 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1;;MHS;;HYPERTHERMIA OF ANESTHESIA;;HYPERPYREXIA, MALIGNANT; MHKING SYNDROME, INCLUDED;;KING-DENBOROUGH SYNDROME, INCLUDED	0.0454545	31.818181818181824
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.0454545	31.818181818181824
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED	0.0454545	31.818181818181824
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.0454545	31.818181818181824
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	0.0454545	31.818181818181824
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.04193089999999999	29.351659351659347
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.04193089999999999	29.351659351659347
ADIPOSIS DOLOROSA	0.04193089999999999	29.351659351659347
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.04049496	28.346500346500353
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0384615	26.923076923076927
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.0384615	26.923076923076927
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.0384615	26.923076923076927
Helsmoortel-van der Aa syndrome	0.0384615	26.923076923076927
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.0384615	26.923076923076927
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.0384615	26.923076923076927
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.0384615	26.923076923076927
COFFIN-SIRIS SYNDROME 1; CSS1	0.0384615	26.923076923076927
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.0384615	26.923076923076927
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.0384615	26.923076923076927
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.0384615	26.923076923076927
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.0384615	26.923076923076927
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0384615	26.923076923076927
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.0384615	26.923076923076927
#137580 GILLES DE LA TOURETTE SYNDROME; GTS;;TOURETTE SYNDROME; TS;;TOURETTE DISORDERCHRONIC MOTOR TICS, INCLUDED	0.0384615	26.923076923076927
KLEEFSTRA SYNDROME	0.0384615	26.923076923076927
COFFIN-SIRIS SYNDROME 7; CSS7	0.0384615	26.923076923076927
TRICHOTILLOMANIA; TTM	0.0384615	26.923076923076927
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.0384615	26.923076923076927
STIFF-PERSON SYNDROME; SPS	0.0343552	24.048664048664055
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.0343552	24.048664048664055
#258450 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL RECESSIVE; PEOB;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE	0.0312357	21.86501186501187
#616000 ANALBUMINEMIA; ANALBA	0.030302999999999997	21.21212121212121
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.030302999999999997	21.21212121212121
CREATINE PHOSPHOKINASE, ELEVATED SERUM	0.030302999999999997	21.21212121212121
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.030302999999999997	21.21212121212121
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.030302999999999997	21.21212121212121
HEMOCHROMATOSIS, TYPE 4; HFE4	0.030302999999999997	21.21212121212121
HEMOCHROMATOSIS, TYPE 3; HFE3	0.030302999999999997	21.21212121212121
#613157 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MDDGC3;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2O; LGMD2O;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMGNT1-RELATED	0.030302999999999997	21.21212121212121
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.030302999999999997	21.21212121212121
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.030302999999999997	21.21212121212121
#133100 ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1;;POLYCYTHEMIA, PRIMARY FAMILIAL AND CONGENITAL; PFCP;;ERYTHROCYTOSIS, AUTOSOMAL DOMINANT BENIGN	0.030302999999999997	21.21212121212121
ANISOCORIA	0.030302999999999997	21.21212121212121
#615399 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2; PNH2	0.030302999999999997	21.21212121212121
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.030302999999999997	21.21212121212121
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.030302999999999997	21.21212121212121
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.030302999999999997	21.21212121212121
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	0.030302999999999997	21.21212121212121
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.030302999999999997	21.21212121212121
#263400 ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2;;ERYTHROCYTOSIS, AUTOSOMAL RECESSIVE BENIGN;;POLYCYTHEMIA, VHL-DEPENDENT;;POLYCYTHEMIA, CHUVASH TYPE	0.030302999999999997	21.21212121212121
SATOYOSHI SYNDROME	0.030302999999999997	21.21212121212121
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.030302999999999997	21.21212121212121
MYXEDEMA	0.030302999999999997	21.21212121212121
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.030302999999999997	21.21212121212121
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.02886706	20.20696220696221
NEMALINE MYOPATHY 6	0.02886706	20.20696220696221
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.02886706	20.20696220696221
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.0227273	15.90912590912591
HYPERHIDROSIS, GUSTATORY	0.0227273	15.90912590912591
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.0227273	15.90912590912591
CLUSTER HEADACHE, FAMILIAL	0.0227273	15.90912590912591
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.0227273	15.90912590912591
MOTOR NEUROPATHY, PERIPHERAL, WITH DYSAUTONOMIA	0.0227273	15.90912590912591
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.0227273	15.90912590912591
#615726 PACHYONYCHIA CONGENITA 3; PC3	0.0227273	15.90912590912591
PARAGANGLIOMAS 3	0.0227273	15.90912590912591
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.0227273	15.90912590912591
BUERGER DISEASE	0.0227273	15.90912590912591
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0227273	15.90912590912591
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.0227273	15.90912590912591
GRANULOSIS RUBRA NASI	0.0227273	15.90912590912591
MAL DE MELEDA	0.0227273	15.90912590912591
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.0227273	15.90912590912591
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.0227273	15.90912590912591
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.0227273	15.90912590912591
ERYTHERMALGIA, PRIMARY	0.0227273	15.90912590912591
NOONAN SYNDROME 7; NS7	0.0227273	15.90912590912591
SANDHOFF DISEASE	0.0227273	15.90912590912591
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.0227273	15.90912590912591
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.0227273	15.90912590912591
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT	0.0227273	15.90912590912591
#610313 COLD-INDUCED SWEATING SYNDROME 2; CISS2	0.0227273	15.90912590912591
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.0227273	15.90912590912591
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.0227273	15.90912590912591
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.0227273	15.90912590912591
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0227273	15.90912590912591
PALMOPLANTAR KERATODERMA I, STRIATE, FOCAL, OR DIFFUSE; PPKS1	0.0227273	15.90912590912591
Ullrich congenital muscular dystrophy 1	0.0227273	15.90912590912591
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	15.90912590912591
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.0227273	15.90912590912591
PARAGANGLIOMAS 1	0.0227273	15.90912590912591
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.0227273	15.90912590912591
#614594 PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTICPLAQUES;;OLMSTED SYNDROME; OLMS	0.0227273	15.90912590912591
%613576 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2	0.0227273	15.90912590912591
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.0227273	15.90912590912591
PARAGANGLIOMAS 4	0.0227273	15.90912590912591
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.0227273	15.90912590912591
ANGIOKERATOMA CORPORIS DIFFUSUM WITH ARTERIOVENOUS FISTULAS	0.0227273	15.90912590912591
PHEOCHROMOCYTOMA	0.0227273	15.90912590912591
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.020887160000000002	14.621026621026623
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.0196078	13.725473725473728
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0196078	13.725473725473728
#612650 CILIARY DYSKINESIA, PRIMARY, 12; CILD12	0.0196078	13.725473725473728
#613561 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	0.0196078	13.725473725473728
GLYCOGEN STORAGE DISEASE XIII; GSD13	0.0196078	13.725473725473728
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0196078	13.725473725473728
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.0196078	13.725473725473728
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.0196078	13.725473725473728
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.0196078	13.725473725473728
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25; LGMDR25	0.0196078	13.725473725473728
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.0196078	13.725473725473728
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0196078	13.725473725473728
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.0196078	13.725473725473728
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.0196078	13.725473725473728
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.0196078	13.725473725473728
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.0196078	13.725473725473728
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.0196078	13.725473725473728
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.0196078	13.725473725473728
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.0196078	13.725473725473728
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.0196078	13.725473725473728
CYCLIC VOMITING SYNDROME	0.0196078	13.725473725473728
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.0196078	13.725473725473728
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.0196078	13.725473725473728
#615418 MITOCHONDRIAL DNA DEPLETION SYNDROME 12 (CARDIOMYOPATHIC TYPE); MTDPS12	0.0196078	13.725473725473728
GLYCOGEN STORAGE DISEASE VII	0.0196078	13.725473725473728
EXERCISE INTOLERANCE, RIBOFLAVIN-RESPONSIVE	0.0196078	13.725473725473728
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0196078	13.725473725473728
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.0196078	13.725473725473728
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.0196078	13.725473725473728
#612649 CILIARY DYSKINESIA, PRIMARY, 11; CILD11	0.0196078	13.725473725473728
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.0196078	13.725473725473728
MUSCLE GLYCOGENOSIS, X-LINKED	0.0196078	13.725473725473728
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.0116279	8.139538139538141
ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9	0.0116279	8.139538139538141
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.0116279	8.139538139538141
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.0116279	8.139538139538141
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.0116279	8.139538139538141
DYSTONIA 26, MYOCLONIC; DYT26	0.0116279	8.139538139538141
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.0116279	8.139538139538141
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.0116279	8.139538139538141
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.0116279	8.139538139538141
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.0116279	8.139538139538141
SPINOCEREBELLAR ATAXIA 27; SCA27	0.0116279	8.139538139538141
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.0116279	8.139538139538141
#221820 LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS; HDLS;;LEUKOENCEPHALOPATHY WITH NEUROAXONAL SPHEROIDS, AUTOSOMAL DOMINANT;;GLIOSIS, FAMILIAL PROGRESSIVE SUBCORTICAL; GPSC;;DEMENTIA, FAMILIAL, NEUMANN TYPE;;SUBCORTICAL GLIOSIS OF NEUMANN	0.0116279	8.139538139538141
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.0116279	8.139538139538141
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.0116279	8.139538139538141
HUNTINGTON DISEASE-LIKE 2	0.0116279	8.139538139538141
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.0116279	8.139538139538141
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.0116279	8.139538139538141
SPINOCEREBELLAR ATAXIA 14	0.0116279	8.139538139538141
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0116279	8.139538139538141
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.0116279	8.139538139538141
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.0116279	8.139538139538141
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.0116279	8.139538139538141
TRIMETHYLAMINURIA	0.0116279	8.139538139538141
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.0116279	8.139538139538141
PERRY SYNDROME	0.0116279	8.139538139538141
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.0116279	8.139538139538141
#137440 GERSTMANN-STRAUSSLER DISEASE; GSD;;ENCEPHALOPATHY, SUBACUTE SPONGIFORM, GERSTMANN-STRAUSSLER TYPE;;GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; GSS;;CEREBELLAR ATAXIA, PROGRESSIVE DEMENTIA, AND AMYLOID DEPOSITS IN CNS;;AMYLOIDOSIS, CEREBRAL, WITH SPONGIFORM ENCEPHALOPATHY;;PRION DEMENTIACEREBRAL AMYLOID ANGIOPATHY, PRNP-RELATED, INCLUDED	0.0116279	8.139538139538141
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.0116279	8.139538139538141
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.0116279	8.139538139538141
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3; FASPS3	0.0116279	8.139538139538141
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.0116279	8.139538139538141
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.0116279	8.139538139538141
HUNTINGTON DISEASE-LIKE 1	0.0116279	8.139538139538141
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.0116279	8.139538139538141
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.0116279	8.139538139538141
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.0116279	8.139538139538141
WOLFRAM SYNDROME 2; WFS2	0.0116279	8.139538139538141
#182601 SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 2; FSP2	0.0116279	8.139538139538141
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.0116279	8.139538139538141
PARKINSON DISEASE, LATE-ONSET; PD	0.0116279	8.139538139538141
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.0116279	8.139538139538141
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.0116279	8.139538139538141
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.0116279	8.139538139538141
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.0116279	8.139538139538141
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.0116279	8.139538139538141
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.0116279	8.139538139538141
Xq28 (MECP2) duplication	0.0116279	8.139538139538141
DYSTONIA 12; DYT12	0.0116279	8.139538139538141
HYPERTRYPTOPHANEMIA; HYPTRP	0.0116279	8.139538139538141
SPINOCEREBELLAR ATAXIA 42	0.0116279	8.139538139538141
SPINOCEREBELLAR ATAXIA 12	0.0116279	8.139538139538141
KOSAKI OVERGROWTH SYNDROME; KOGS	0.0116279	8.139538139538141
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.0116279	8.139538139538141
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.0116279	8.139538139538141
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.0116279	8.139538139538141
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.0116279	8.139538139538141
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.0116279	8.139538139538141
MAJOR AFFECTIVE DISORDER 1	0.0116279	8.139538139538141
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.0116279	8.139538139538141
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.0116279	8.139538139538141
HUNTINGTON DISEASE; HD	0.0116279	8.139538139538141
CREUTZFELDT-JAKOB DISEASE; CJD	0.0116279	8.139538139538141
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1; FASPS1	0.0116279	8.139538139538141
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.0116279	8.139538139538141
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.0116279	8.139538139538141
MARINESCO-SJOGREN SYNDROME; MSS	0.00925926	6.4814884814884826
MYOPATHY, DISTAL, 5; MPD5	0.00925926	6.4814884814884826
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.00925926	6.4814884814884826
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00925926	6.4814884814884826
CARNITINE DEFICIENCY, MYOPATHIC	0.00925926	6.4814884814884826
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.00925926	6.4814884814884826
#232400 GLYCOGEN STORAGE DISEASE III;;GSD III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCYGLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED	0.00925926	6.4814884814884826
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00925926	6.4814884814884826
300270 ADRENOMYODYSTROPHY	0.00925926	6.4814884814884826
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.00925926	6.4814884814884826
MYOPATHY, DISTAL, 4; MPD4	0.00925926	6.4814884814884826
DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	0.00925926	6.4814884814884826
#605355 NEMALINE MYOPATHY 5; NEM5;;NEMALINE MYOPATHY, AMISH TYPE; ANM;;AMISH NEMALINE MYOPATHY	0.00925926	6.4814884814884826
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00925926	6.4814884814884826
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.00925926	6.4814884814884826
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.00925926	6.4814884814884826
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00925926	6.4814884814884826
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.00925926	6.4814884814884826
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.00925926	6.4814884814884826
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00925926	6.4814884814884826
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.00925926	6.4814884814884826
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00925926	6.4814884814884826
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00925926	6.4814884814884826
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.00925926	6.4814884814884826
GLYCEROL KINASE DEFICIENCY; GKD	0.00925926	6.4814884814884826
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	0.00925926	6.4814884814884826
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.00925926	6.4814884814884826
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.00925926	6.4814884814884826
CARDIOMYOPATHY ASSOCIATED WITH MYOPATHY AND SUDDEN DEATH	0.00925926	6.4814884814884826
MYOPATHY, CONGENITAL	0.00925926	6.4814884814884826
MYOPATHY WITH STORAGE OF GLYCOPROTEINS AND GLYCOSAMINOGLYCANS	0.00925926	6.4814884814884826
#610140 HEART-HAND SYNDROME, SLOVENIAN TYPE	0.00925926	6.4814884814884826
ADDUCTED THUMBS SYNDROME	0.00925926	6.4814884814884826
HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2	0.00925926	6.4814884814884826
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.00925926	6.4814884814884826
FINGERPRINT BODY MYOPATHY	0.00925926	6.4814884814884826
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00925926	6.4814884814884826
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00925926	6.4814884814884826
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.00925926	6.4814884814884826
MYOPATHY, SPHEROID BODY	0.00925926	6.4814884814884826
BETHLEM MYOPATHY 2; BTHLM2	0.00925926	6.4814884814884826
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.00925926	6.4814884814884826
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.00925926	6.4814884814884826
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.00925926	6.4814884814884826
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00925926	6.4814884814884826
#535000 LEBER OPTIC ATROPHY;;LEBER HEREDITARY OPTIC NEUROPATHY; LHON	0.00925926	6.4814884814884826
#170400 HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1; HOKPP1;;HYPOKALEMIC PERIODIC PARALYSIS; HOKPP	0.00925926	6.4814884814884826
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.00925926	6.4814884814884826
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.00925926	6.4814884814884826
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.00925926	6.4814884814884826
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.00925926	6.4814884814884826
STROMME SYNDROME; STROMS	0.00925926	6.4814884814884826
#310440 MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX;;XMEA	0.00925926	6.4814884814884826
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00925926	6.4814884814884826
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.00925926	6.4814884814884826
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00925926	6.4814884814884826
#160565 MYOPATHY, TUBULAR AGGREGATE, 1; TAM1;;MYOPATHY, TUBULAR AGGREGATE; TAM;;TUBULAR AGGREGATE MYOPATHY	0.00925926	6.4814884814884826
SALIH MYOPATHY; SALMY	0.00925926	6.4814884814884826
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00925926	6.4814884814884826
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00925926	6.4814884814884826
BETHLEM MYOPATHY 1	0.00925926	6.4814884814884826
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.00925926	6.4814884814884826
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3; IBMPFD3	0.00925926	6.4814884814884826
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.00925926	6.4814884814884826
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00925926	6.4814884814884826
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.00925926	6.4814884814884826
STORMORKEN SYNDROME; STRMK	0.00925926	6.4814884814884826
IMMUNODEFICIENCY 9; IMD9	0.00925926	6.4814884814884826
IMMUNODEFICIENCY 10; IMD10	0.00925926	6.4814884814884826
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.00925926	6.4814884814884826
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00925926	6.4814884814884826
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.00925926	6.4814884814884826
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00925926	6.4814884814884826
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.00925926	6.4814884814884826
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00925926	6.4814884814884826
XANTHINURIA, TYPE I	0.00925926	6.4814884814884826
HYPOPHOSPHATASIA, CHILDHOOD	0.00925926	6.4814884814884826
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.00925926	6.4814884814884826
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00925926	6.4814884814884826
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00925926	6.4814884814884826
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00925926	6.4814884814884826
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.00925926	6.4814884814884826
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.00925926	6.4814884814884826
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.00925926	6.4814884814884826
MUSCULAR DYSTROPHY, BARNES TYPE	0.00925926	6.4814884814884826
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.00925926	6.4814884814884826
AXIAL OSTEOMALACIA	0.00925926	6.4814884814884826
MYOPATHY DUE TO MALATE-ASPARTATE SHUTTLE DEFECT	0.00925926	6.4814884814884826
MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT	0.00925926	6.4814884814884826
#300695 SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT; SPM;;SCAPULOPERONEAL MYOPATHY, FHL1-RELATED	0.00925926	6.4814884814884826
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00925926	6.4814884814884826
VICI SYNDROME; VICIS	0.00925926	6.4814884814884826
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00925926	6.4814884814884826
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00925926	6.4814884814884826
CHANARIN-DORFMAN SYNDROME	0.00925926	6.4814884814884826
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00925926	6.4814884814884826
